`Date Filed: Jan. 14, 2016
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMERIGEN PHARMACEUTICALS LIMITED
`Petitioner,
`
`v.
`
`JANSSEN ONCOLOGY, INC.,
`Patent Owner.
`
`________________
`
`Case IPR2016-00286
`Patent 8,822,438 B2
`
`________________
`
`
`DECLARATION OF BINDU DONOVAN IN
`SUPPORT OF MOTION TO APPEAR PRO HAC VICE
`
`
`
`
`
`
`
`
`JANSSEN EXHIBIT 2002
`
`
`
`IPR2016-00286
`Patent No. 8,822,438 B2
`
`I, Bindu Donovan, declare as follows:
`
`1. I am a partner in the New York Office of Sidley Austin LLP. I have personal
`
`knowledge of the facts set forth in this declaration and, if called as a witness, could
`
`and would testify competently under oath.
`
`2. I am a member in good standing of the State Bar of New York (Bar No.
`
`2977981).
`
`3. I have never been suspended or disbarred from practice before any court or
`
`administrative body.
`
`4. None of my applications for admission to practice before any court or
`
`administrative body have ever been denied.
`
`5. I have not been sanctioned nor have I had a contempt citation imposed on
`
`me by any court or administrative body.
`
`6. I have read and will comply with the Office Patent Trial Practice Guide and
`
`the Board’s Rules of Practice for Trial set forth in part 42 of 37 C.F.R.
`
`7. I acknowledge and agree that I will be subject to the USPTO Rules of
`
`Professional Conduct set forth in 37 C.F.R. § 11.101 et. seq. and disciplinary
`
`jurisdiction under 37 C.F.R. § 11.19(a).
`
`8. I have not applied to appear pro hac vice before the Patent Trial and Appeal
`
`Board in the last three years.
`
`
`
`2
`
`
`
`IPRZO l 6-00286
`
`Patent No. 8,822,438 B2
`
`9.
`
`I have been a practicing attorney for over 15 years and have been involved
`
`in numerous patent cases.
`
`I am presently counsel for Patent Owner Janssen
`
`Oncology, Inc. in two pending patent litigations‘ involving the patent under review
`
`in this proceeding, U.S. Patent No. 8,822,438 (the “’438 patent”). As part of these
`
`litigations, I have studied and analyzed the ’438 patent and have become very
`
`familiar with its subject matter.
`
`I have also gained familiarity with certain prior art
`
`(including prior art asserted in this IPR proceeding), conception and reduction to
`
`practice of the inventions claimed in the ’438 patent, and other relevant issues,
`
`including claim construction of various claim terms.
`
`I declare under penalty of perjury that the foregoing is true and correct.
`
`Executed on January H , 2016 in New York, New York.
`
`By:
`
` £%
`
`Bindu Donovan
`
`‘ BTG Int’! Ltd, er al. v. Actavis Labs. FL, Ina, ez‘ aZ., C.A. No. 2:l5—cv—
`
`O5909—KM—JBC (D.N.J.) and Jcmssen Biotech, Inc., et al. v. Mylar; Pharm. Inc, et
`
`al., C.A. No. 1:l5—cv—00l30~IMK (N.D. W. Va.).
`
`
`
`IPR2016-00286
`Patent No. 8,822,438 B2
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Declaration of
`
`Bindu Donovan in Support of Motion to Appear Pro Hac Vice was served on
`
`counsel of record on January 14, 2016 by filing this document through the Patent
`
`Review Processing System, as well as delivering a copy via electronic mail to
`
`counsel of record for the Petitioner at the following addresses:
`
`William Hare
`Gabriela Materassi
`McNeeley Hare & War LLP
`bill@miplaw.com
`materassi@miplaw.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`By: /Dianne B. Elderkin/
`Dianne B. Elderkin
`Registration No. 28,598
`Counsel for Patent Owner
`
`4
`
`
`
`
`
`Date: January 14, 2016